Product
Help
Pricing
About
Jobs
Log in
Get started
Award
Add to collection
Malaria Vaccine: Pfs230-rEPA
Funder:
National Institute of Allergy and Infectious Diseases
Funding type:
intramural
Funder scheme:
ZIA
Investigator:
PATRICK DUFFY
Institution:
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Funded outputs count:
3
Funder award ID:
ZIAAI001010
OpenAlex ID:
G7749960066
Malaria transmission-blocking vaccines Pfs230D1-EPA and Pfs25-EPA in Alhydrogel in healthy Malian adults; a phase 1, randomised, controlled trial
2023
·
Issaka Sagara
, Sara A Healy
, et al.
·
The Lancet Infectious Diseases
·
52
PDF
B cell clonal expansion and mutation in the immunoglobulin heavy chain variable domain in response to Pfs230 and Pfs25 malaria vaccines
2021
·
Camila H. Coelho
, Jacob D. Galson
, et al.
·
International Journal for Parasitology
·
5
Utilizing direct skin feeding assays for development of vaccines that interrupt malaria transmission: A systematic review of methods and case study
2016
·
Elizabeth B. Brickley
, Mamadou Coulibaly
, et al.
·
Vaccine
·
14
Show more works
View as search
Year
Topic
